Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1063 | 926 | 1116 | 1003 | 1269 | 1540 |
Fund Return | 6.35% | -7.4% | 11.62% | 0.1% | 4.88% | 4.41% |
Place in category | 23 | 62 | 23 | 64 | 62 | 35 |
% in Category | 21 | 76 | 21 | 76 | 75 | 75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 619.45B | 28.05 | 11.42 | 13.34 | ||
Fidelity Contrafund | 140.4B | 37.26 | 11.61 | 15.33 | ||
Fidelity Contrafund K | 12.59B | 37.40 | 11.71 | 15.44 | ||
Fidelity Total Market Index Instl b | 104.68B | 27.73 | 10.41 | 12.84 | ||
Fidelity Blue Chip Growth | 67.04B | 37.89 | 9.30 | 17.88 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard European Stock Index Adm | 4.77B | 4.71 | 3.74 | 5.05 | ||
Vanguard European Stock Index I | 827.85M | 4.73 | 3.76 | 5.07 | ||
DFA Continental Small Company I | 110.83M | 1.82 | -0.15 | 7.25 | ||
T. Rowe Price European Stock | 413.17M | 3.84 | 0.29 | 4.31 | ||
Brown Advisory WMC Strat Eurp Eq In | 320.98M | 13.22 | 8.34 | 7.80 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.49 | 602.8 | -2.51% | |
ASML Holding | NL0010273215 | 4.67 | 738.40 | -1.26% | |
SAP | DE0007164600 | 3.90 | 243.300 | +1.69% | |
AstraZeneca | GB0009895292 | 3.65 | 10,668.0 | -0.41% | |
Shell | GB00BP6MXD84 | 2.67 | 31.78 | +1.21% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Strong Sell |
Technical Indicators | Sell | Strong Sell | Sell |
Summary | Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review